Form 8-K - Current report:
SEC Accession No. 0001628280-24-045022
Filing Date
2024-11-04
Accepted
2024-11-04 16:28:22
Documents
26
Period of Report
2024-11-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K abcl-20241104.htm   iXBRL 8-K 27598
2 EX-99.1 q32024earningspressrelease.htm EX-99.1 173069
3 EX-99.2 q3presentationdeckfinal.htm EX-99.2 8659
7 capture.jpg GRAPHIC 48406
8 q3presentationdeckfinal001.jpg GRAPHIC 44498
9 q3presentationdeckfinal002.jpg GRAPHIC 103794
10 q3presentationdeckfinal003.jpg GRAPHIC 88776
11 q3presentationdeckfinal004.jpg GRAPHIC 62896
12 q3presentationdeckfinal005.jpg GRAPHIC 83875
13 q3presentationdeckfinal006.jpg GRAPHIC 70758
14 q3presentationdeckfinal007.jpg GRAPHIC 67547
15 q3presentationdeckfinal008.jpg GRAPHIC 45548
16 q3presentationdeckfinal009.jpg GRAPHIC 59530
17 q3presentationdeckfinal010.jpg GRAPHIC 62882
  Complete submission text file 0001628280-24-045022.txt   1359260

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abcl-20241104.xsd EX-101.SCH 1788
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abcl-20241104_lab.xml EX-101.LAB 20678
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abcl-20241104_pre.xml EX-101.PRE 11962
29 EXTRACTED XBRL INSTANCE DOCUMENT abcl-20241104_htm.xml XML 2593
Mailing Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1
Business Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1 (604) 559-9005
AbCellera Biologics Inc. (Filer) CIK: 0001703057 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39781 | Film No.: 241424001
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)